Dronedarone: in quest of the ideal antiarrhythmic drug.
Kayser
Steven R
SR
Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, CA 94142-0622, USA. kaysers@pharmacy.ucsf.edu
D000638:Amiodarone / Q000031:analogs & derivatives* / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001682:Biological Availability; D017326:Clinical Trials, Phase III as Topic; D000077764:Dronedarone; D004347:Drug Interactions; D004594:Electrophysiology; D006801:Humans; D012449:Safety; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D000077764:Dronedarone; D000638:Amiodarone